Belite Bio, Inc Receives 41.00 Average Price Target from Analysts

BLTE Stock  USD 64.00  0.74  1.17%   
About 62% of all Belite Bio's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Belite Bio ADR suggests that some traders are interested. The current market sentiment, together with Belite Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Belite Bio ADR stock news signals to limit their universe of possible portfolio assets.
  
Shares of Belite Bio, Inc have been given a consensus rating of Buy by the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued a report on

Read at thelincolnianonline.com
news
  

Belite Bio Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Belite Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Belite Bio Fundamental Analysis

We analyze Belite Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Belite Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Belite Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Belite Bio is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Belite Bio ADR Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Belite Bio stock to make a market-neutral strategy. Peer analysis of Belite Bio could also be used in its relative valuation, which is a method of valuing Belite Bio by comparing valuation metrics with similar companies.

Peers

Belite Bio Related Equities

GLTOGalecto   6.98   
0%
96.0%
MLYSMineralys Therapeutics,   5.64   
0%
78.0%
PMVPPmv Pharmaceuticals   4.32   
0%
59.0%
TRDAEntrada Therapeutics   2.16   
0%
29.0%
AVTEAerovate Therapeutics   1.14   
0%
15.0%
AADIAadi Bioscience   0.85   
0%
11.0%
ALGSAligos Therapeutics   0.82   
0%
11.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
9.0%
IMRXImmuneering Corp   0.48   
0%
6.0%
IKNAIkena Oncology   1.16   
16.0%
0%
CELCCelcuity LLC   1.33   
18.0%
0%
GLUEMonte Rosa   1.35   
18.0%
0%
ACRVAcrivon Therapeutics,   1.85   
25.0%
0%
LRMRLarimar Therapeutics   2.05   
28.0%
0%
ANABAnaptysBio   2.32   
32.0%
0%
VIGLVigil Neuroscience   2.83   
39.0%
0%
ANTXAN2 Therapeutics   4.19   
58.0%
0%
CNTACentessa Pharmaceuticals   5.36   
74.0%
0%
ADAGAdagene   6.41   
88.0%
0%
MOLNMolecular Partners   7.22   
100.0%
0%

Complementary Tools for Belite Stock analysis

When running Belite Bio's price analysis, check to measure Belite Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Belite Bio is operating at the current time. Most of Belite Bio's value examination focuses on studying past and present price action to predict the probability of Belite Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Belite Bio's price. Additionally, you may evaluate how the addition of Belite Bio to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios